Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by gottahunchon Dec 17, 2020 8:50am
239 Views
Post# 32126574

$12 USD PT from Alliance

$12 USD PT from Alliancehttps://www.marketbeat.com/instant-alerts/nyse-apha-a-buy-or-sell-right-now-2020-12/

Alliance Global Partners Boosts Aphria (NYSE:APHA) Price Target to $12.00

WEDNESDAY, DECEMBER 16, 2020 | MARKETBEAT

Aphria (NYSE:APHA) had its price target hoisted by equities research analysts at Alliance Global Partners from $9.00 to $12.00 in a research report issued on Wednesday, The Fly reports. The firm currently has a "buy" rating on the stock. Alliance Global Partners' price target points to a potential upside of 48.88% from the company's current pric


<< Previous
Bullboard Posts
Next >>